An HIV/AIDS treatment developed by GlaxoSmithKline (NYSE:GSK) is now being studied with Siemens (NYSE:SI) to develop companion diagnostics that doctors can use to select patients appropriate for the treatment.The partnership with ViiV Healthcare, GSK’s AIDS drug joint venture with Pfizer (NYSE:PFE), will study the drug Selzentry in a phase 3 study comparing it to another [...]

A newly formed University of Illinois spinoff company could be on to something good with a new drug treatment for cancer that targets an enzyme commonly found in various tumor types.Department of Chemistry professor Paul Hergenrother and a handful of other co-founders of Vanquish Oncology are developing compounds that selectively kill cancer cells by targeting [...]

Behavioral health personalized medicine company AssureRx Health has secured an $8 million line of credit as it looks to boost adoption of its genetic screening test for psychiatric drugs.Along with an $11 million series B round of funding that the company obtained last year, the line of credit will help fund the development of several [...]

Selventa, a biomarker discovery company that enables personalized healthcare through the stratification of patients based on disease-driving mechanisms, recently announced a US patent that relates methods and techniques that facilitate discovery of biomarkers, thus aiding in the development of predictive and prognostic diagnostic tests for therapeutics targeting complex multi-factorial diseases.The Massachusetts-based company uses molecular patient [...]

Molecular diagnostics technology developed by Cooperative Diagnostics has caught the eye of United Kingdom firm Lab21 Limited, which has signed an exclusive worldwide license to develop the technology into new personalized medicine tests.No financial terms between Lab21 and Greenwood, South Carolina-based Cooperative Diagnostics were disclosed. Cooperative Diagnostics has developed custom nucleic acid tests that it [...]

Quintiles is expanding its reach in personalized medicine, forming a new company that will conduct biomarker research and development in cancer.The company, Oxford Cancer Biomarkers, is based on technology developed at the University of Oxford. CancerNav is a proprietary DNA and protein-based test technology platform that can quickly identify biomarkers that can be used in [...]

Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs.The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical algorithms and bioinformatics to narrow drug choices to [...]

Dr. Eric Topol is hoping the Digital Health Summit at CES will kickstart a consumer health revolution needed to improve patient access to information and drive down healthcare costs.Wednesday’s opening panel discussion was chock-full of soundbites from Scripps Translational Science Institute Chief Academic Officer Topol, Life Technologies CEO Greg Lucier — who said technology is [...]

The Is My Cancer Different? campaign urges patients to ask their doctors a crucial question ’ is my cancer different? ’ and provides powerful information on why, when and how it could matter to their treatment choices.Presented in video format and featuring cancer survivors, physicians, scientists, advocates and Ronnie Andrews, the president of Clarient, the [...]

The big future of life sciences innovation means thinking small. Forbes magazine now has a list of the 30 “disruptors” under 30 in 12 different fields. In the sciences category, individuals whose work touches on DNA or genetics research dominate the field.Forbes selected as its featured science innovator Daniela Witten, 27, a University of Washington [...]